Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

RESTAT Launches Align, a Cost-Plus, Fee for Service Pharmacy Benefits Pricing (PBM) Model


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-11-17 14:01:05 -

RESTAT : , rated as the sixth largest Pharmacy Benefit Manager (PBM) in the U.S.

according to Business Insurance, recently launched Align, : an innovative new program that combines a preferred pharmacy network with cost-plus pricing. Following a one-year pilot program with Caterpillar Inc. and WalMart, RESTAT is launching Align as a proven way for self

insured employers to reduce the cost of their pharmacy benefit.

“With the success of our pilot, we are now offering this unique new model, as a way to drive down prescription costs for employers, employees, and their families,” said RESTAT President David Kwasny.


According to Kwasny, the Align program reduces cost and complexity by replacing the traditional pricing methodology based upon AWP (average wholesale price) with a simple “cost-plus fee for service” pricing. “RESTAT works with employers and a pool of pharmacies – liberating the marketplace by stimulating competition for the lowest drug cost,” said Kwasny. “The Align model can be tailored to the specific goals of an employer and its employee base – focusing on the concerns they see as primary – lower costs or more comprehensive benefits.”

Kwasny said RESTAT is a uniquely qualified as a PBM to provide this offering, “We don’t own, nor are we owned by a retail, wholesale or mail order pharmacy. This allows us to provide unbiased benefits advice based on cost and quality – free of any conflict of interest. And because we’re privately held, we have an opportunity to think longer term with our clients. We can create more strategic solutions.”


“We’ve been a client of RESTAT’s since the early 1990s,” said Caterpillar Inc. Pharmacy & Informatics Manager, Todd Bisping. “Their new program is consistent with Caterpillar's goal to reduce complexity and provide transparent, cost plus prescription drug pricing which has enabled us to achieve significant savings this past year as a result.”


The Align network currently includes nearly one-third of all pharmacies in the nation.

Kwasny said the Align pricing model is one way RESTAT is fulfilling its mission to simplify the purchase and use of health care services through independent benefits management. “We want to make it easier for self-insured employers to manage their healthcare costs without relinquishing quality healthcare benefits.”

ABOUT RESTAT:


A member of the Dohmen : family of companies, RESTAT simplifies the purchase and use of healthcare services through independent benefits management. As the largest independent PBM, RESTAT has no ownership ties to drug manufacturers or distribution channels, making it uniquely positioned to provide customers with unbiased benefit management solutions. With more than 25 years of experience managing pharmacy benefits, RESTAT is also one of the world’s most experienced benefit managers. Today, more than 4,200 companies, ranging in size from the Fortune 50 to small managed care organizations rely on RESTAT to manage the prescription benefit for over 7.5 million people nationwide. To learn more, visit www.restat.com : or call 800.926.5858.


Carole PfeilVice President, Corporate

CommunicationsDohmen (Parent Company of RESTAT)414.299.4914 Cpfeil@dohmen.com : mailto:Cpfeil@dohmen.com


Disclaimer: (c) 2010 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com